Submission of Scrutinizer Report for the Extra-Ordinary General Meeting of the Company held on 3rd June, 2025 at 03:02 PM through VC/OAVM.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Evoq Remedies Limited held an Extra-Ordinary General Meeting (EGM) on 3rd June 2025 at 3:02 PM through video conferencing. Five resolutions were put to vote via remote e-voting (held from 31st May to 2nd June 2025). All 5 resolutions were passed unanimously with 28,07,787 votes (100%) cast in favour, zero votes against, and zero invalid votes. The cut-off date for voting eligibility was 27th May 2025. The company is listed on the BSE SME platform, and the scrutinizer was Gaurav Bachani & Associates, Company Secretaries.
The 100% unanimous approval across all resolutions signals strong shareholder consensus, though this pattern is common among BSE SME-listed companies with promoter-dominated shareholding and limited public float participation. The actual substance of the resolutions (not disclosed in the scrutinizer report) would determine any meaningful price impact.